Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Equity Ratio (2023 - 2026)

Camp4 Therapeutics' Equity Ratio history spans 3 years, with the latest figure at 0.4 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 49.78% to 0.4 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.4, a 49.78% decrease, with the full-year FY2025 number at 0.4, down 49.78% from a year prior.
  • Equity Ratio hit 0.4 in Q4 2025 for Camp4 Therapeutics, down from 0.68 in the prior quarter.
  • Over the last five years, Equity Ratio for CAMP hit a ceiling of 0.82 in Q1 2025 and a floor of 7.44 in Q3 2024.
  • Historically, Equity Ratio has averaged 0.89 across 3 years, with a median of 0.68 in 2025.
  • Biggest five-year swings in Equity Ratio: surged 135.81% in 2024 and later tumbled 49.78% in 2025.
  • Tracing CAMP's Equity Ratio over 3 years: stood at 2.25 in 2023, then surged by 135.81% to 0.81 in 2024, then tumbled by 49.78% to 0.4 in 2025.
  • Business Quant data shows Equity Ratio for CAMP at 0.4 in Q4 2025, 0.68 in Q3 2025, and 0.78 in Q2 2025.